Acorda Therapeutics Stock Price

0.0099 (1.92%)
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Acorda Therapeutics Inc ACOR NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0099 1.92% 0.5249 16:15:44
Close Price Low Price High Price Open Price Previous Close
0.5221 0.481 0.5275 0.5014 0.515
Bid Price Ask Price Spread News
0.5175 0.528 0.0105 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
5,447 2,984,372 $ 0.5026039 $ 1,499,957 5,246,492 0.402 - 3.14
Last Trade Time Type Quantity Stock Price Currency
16:15:19 formt 200 $ 0.5249 USD

Acorda Therapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 24.69M 47.97M 42.25M $ 192.41M $ - -5.75 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - 2.40%

more financials information »

Acorda Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ACOR Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.480.8550.460.606436324,841,5190.04499.35%
1 Month0.52470.8550.4020.59220077,202,5240.00020.04%
3 Months0.71951.050.4020.63605453,873,309-0.1946-27.05%
6 Months0.92321.37110.4020.72242892,801,488-0.3983-43.14%
1 Year2.883.140.4021.262,442,090-2.36-81.77%
3 Years23.6536.350.4026.971,384,308-23.13-97.78%
5 Years26.6143.630.40211.471,111,857-26.09-98.03%

Acorda Therapeutics Description

Acorda Therapeutics is a biopharmaceutical company focused on developing therapies that restore function and improve the lives of people with neurological disorders. Acorda uses scientific, clinical, and commercial expertise in neurology as strategic points of access in additional nervous system markets, including stroke, Parkinson's disease, and epilepsy. The company does not operate separate lines of business with respect to any of its products or product candidates. All of its net product revenue is derived from the United States.

Your Recent History
Acorda The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.